Tester David J, Ackerman Michael J
Departments of Medicine, Pediatrics, and Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota 55905, USA.
Annu Rev Med. 2009;60:69-84. doi: 10.1146/annurev.med.60.052907.103838.
In the past decade there has been an increasing awareness of distinct, potentially lethal heritable cardiomyopathic and channelopathic syndromes as they pertain to sudden cardiac death in infants and children. This review highlights current clinical and molecular findings of two highly relevant structural cardiac abnormalities evident at autopsy, namely hypertrophic cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy, as well as the cardiac channelopathies of long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, Brugada syndrome, and short QT syndrome, which may account for one third of autopsy-negative sudden unexplained deaths (SUDs) during childhood and adolescence. We also explore the role of postmortem genetic analysis (molecular autopsy) in cases of SUD, provide a critical analysis of the current spectrum and prevalence of channelopathies as the pathogenic basis for sudden infant death syndrome (SIDS), and provide a brief synopsis on genetic testing for such potentially lethal cardiac disorders.
在过去十年中,人们越来越意识到,与婴幼儿和儿童心源性猝死相关的独特的、具有潜在致命性的遗传性心肌病和离子通道病综合征。本综述重点介绍了两种在尸检时明显可见的高度相关的心脏结构异常的当前临床和分子研究结果,即肥厚型心肌病和致心律失常性右室心肌病,以及长QT综合征、儿茶酚胺能多形性室性心动过速、Brugada综合征和短QT综合征等心脏离子通道病,这些疾病可能占儿童和青少年尸检阴性的不明原因猝死(SUD)的三分之一。我们还探讨了死后基因分析(分子尸检)在SUD病例中的作用,对目前作为婴儿猝死综合征(SIDS)致病基础的离子通道病的范围和患病率进行了批判性分析,并简要概述了针对此类潜在致命性心脏疾病的基因检测。